Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Dr. Lal Pathlabs Ltd. Share Price
Day's Range
Day's Range
Low
₹1,629.30
High
₹1,698.00
Price Summary
| Previous Close | ₹1,652.40 |
|---|---|
| Day's Range | ₹1,629.30 - ₹1,698.00 |
| Open | ₹1,637.90 |
| 52 Week Range | ₹1,272.60 - ₹1,770.00 |
| Volume | 9,37,712 |
| Market Cap | ₹0.03 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 15,667.20 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 1.24 |
| Price/Earning (TTM) | 54.84 |
| TTM EPS (₹) | 30.11 |
| P/E Ratio | 42.52 |
| Book Value(₹) | 11.04 |
| PAT Margin (%) | 20.00 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 31.53 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5772.0 | 23516.0 |
| Expenses | N/A | N/A |
| PBT | 1449.0 | 6213.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1484.0 | 4973.0 |
About Dr. Lal Pathlabs Ltd.
| Founded | 1995 |
|---|---|
| NSE Symbol | LALPATHLAB |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,251.48 | 1,872.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,242.24 | 6,728.70 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,52,951.96 | 4,512.30 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,16,191.66 | 8,085.00 | 6,677.50 - 6,677.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,811.05 | 1,282.15 | 1,138.50 - 1,138.50 |
| Cipla Ltd. | 1,05,391.40 | 1,304.70 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,02,674.68 | 2,249.70 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,01,937.63 | 2,456.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,01,003.24 | 1,040.85 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 96,261.37 | 956.65 | 835.50 - 835.50 |
No Records Found
Latest News
Dr. Lal PathLabs informs about update on acquisition
Dr. Lal PathLabs informs about analysts meet
Solara Active Pharma Sciences informs about analyst meet
Solara Active Pharma Sciences has informed that the Company has scheduled a conference call with analysts/ investors to discuss Company’s audited financial results for the quarter and financial year ended March 31, 2026 on Friday, May 15, 2026 at 03:00 pm (IST). Analysts / Investors Conference Call details are enclosed. Further, the above information will also be available on the website of the Company: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations.
The above information is a part of company’s filings submitted to BSE.
Sai Life Sciences informs about earnings conference call
Beryl Drugs informs about outcome of EGM
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Dr. Lal Pathlabs Ltd. is ₹1,652.40 as of 2026-05-11.
The market capitalisation of Dr. Lal Pathlabs Ltd. is ₹27,683.70 as of 2026-05-11.
The 1-year return of Dr. Lal Pathlabs Ltd. is 0.00% as of 2026-05-11.
The P/E ratio of Dr. Lal Pathlabs Ltd. is 42.52 as of 2026-05-12.
The 52-week high and low of Dr. Lal Pathlabs Ltd. are ₹1,770.00 and ₹1,272.60, respectively, as of 2026-05-11.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
